CINV: Chemotherapy-Induced Nausea and Vomiting – Antiemetics
Description
The MOQC Chemotherapy-Induced Nausea and Vomiting (CINV) – Antiemetics initiative aims to improve the quality of care provided to patients receiving chemotherapy throughout Michigan. The initiative supports practices in conducting baseline assessments, implementing quality improvement processes, and providing resources for provider and patient education.
Practice Benefits
- Access to current patient and provider resources for CINV symptom management
- Available performance data in the area of CINV guideline adherence
- Opportunities to improve value-based reimbursement (VBR) targets
- Sharing best practices and processes
Antiemetics Team
Emily Mackler, PharmD, BCOP
Director, POEM
estunteb@med.umich.edu
Ashley Bowen, MS, RD
Senior Project Manager
abowen@moqc.org
Resources
- Site visits/phone calls as needed
- Support in identifying gaps in care and targeted quality improvement measures
- Data analysis and report to practice
- Support in abstract, poster and/or manuscript writing and submission
- Resources Page
- Keynote Slides from January, 2022 Biannual Meeting: Chemotherapy-Induced Nausea and Vomiting (CINV): General Principles and Current Standard of Care
- Slides from January, 2022 Biannual Meeting: Increasing the Use of Olanzapine in Patients Receiving Chemotherapy in a Community Practice
Contact Information
For more information, please contact moqc@moqc.org
